Literature DB >> 8616779

Quantification of C-ERB-B2 gene amplification in breast cancer cells using fluorescence in situ hybridization and digital image analysis.

J L Fernández1, V Goyanes, C López-Fernández, I Buño, J Gosálvez.   

Abstract

Fluorescence in situ hybridization (FISH) allows detection of the intercellular heterogeneity of C-ERB-B2 gene amplification in uncultured breast cancer cells. Nevertheless, because high levels of amplification result in coalescence of signals, direct microscopy quantification is restricted to cells wih low levels of amplification or with dispersed signals. A methodology of digital image analysis, using surface and grey-level FISH signals as parameters that permit a rapid, objective, and accurate estimation of gene copy number, is presented. This procedure is independent of the signal overlapping and results in a more accurate quantification and characterization of tumor cell heterogeneity.

Entities:  

Mesh:

Year:  1996        PMID: 8616779     DOI: 10.1016/0165-4608(95)00176-x

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

Review 1.  Quantitative image analysis in mammary gland biology.

Authors:  Rodrigo Fernandez-Gonzalez; Mary Helen Barcellos-Hoff; Carlos Ortiz-de-Solórzano
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-10       Impact factor: 2.673

2.  NEU overexpression in the furan rat model of cholangiocarcinogenesis compared with biliary ductal cell hyperplasia.

Authors:  A E Sirica; S Radaeva; N Caran
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

3.  A modified approach for I-FISH evaluation of ERBB2 (HER-2) gene copy numbers in breast carcinomas: comparison with HER-2/CEP17 ratio system.

Authors:  Marcela Mrhalova; Roman Kodet
Journal:  J Cancer Res Clin Oncol       Date:  2006-12-13       Impact factor: 4.553

4.  Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics.

Authors:  H Engel; C Kleespies; J Friedrich; M Breidenbach; A Kallenborn; T Schöndorf; H Kolhagen; P Mallmann
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.